Expression of MMP-2, MMP-9, and NGAL in Tissue and Serum of Patients with Vascular Aneurysms and Their Modulation by Statin Treatment: A Pilot Study

Abstract

Background: Matrix metalloproteinases (MMPs) are involved in vascular wall degradation, and drugs able to modulate MMP activity can be used to prevent or treat aneurysmal disease. In this study, we evaluated the effects of statins on MMP-2, MMP-9, and neutrophil gelatinase-associated lipocalin (NGAL) in both plasma and tissue in patients with aneurysmal disease. Methods: We performed a prospective, single-blind, multicenter, control group clinical drug trial on 184 patients of both sexes >18 years old with a diagnosis of arterial aneurysmal disease. Enrolled patients were divided into two groups: Group I under statin treatment and Group II not taking statins. In addition, 122 patients without aneurysmal disease and under statin treatment were enrolled as a control group (Group III). The expression of MMPs and NGAL in plasma was evaluated using ELISA, while their expression in endothelial tissues was evaluated using Western blot. Results: The ELISA test revealed greater plasma levels (p < 0.01) of MMPs and NGAL in Groups I and II vs. Group III. Western blot analysis showed higher expression (p < 0.01) of MMPs and NGAL in Group II vs. Group I, and this increase was significantly higher (p < 0.01) in patients treated with low potency statins compared to high potency ones. Conclusions: MMPs and NGAL seem to play a major role in the development of aneurysms, and their modulation by statins suggests that these drugs could be used to prevent arterial aneurysmal disease.

Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role

“…HMG-CoA reductase inhibition blocks the production of these compounds, acting on RAS. In fact, simvastatin and rosuvastatin seem to block SCLC line growth, inhibiting this target and reducing its expression in an in vitro study on SCLC patient samples [ 21 , 39 ].…”

Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia

“…These results are coherent with seminal papers published during the last 10 years and systematically describe a hepatoprotective effect of simvastatin and other biosimilars, to the point of considering statins a potential class of drugs to prevent liver-related mortality in daily practice [ 16 ]. This important achievement is sustained by the so-called pleiotropic effects of statins predominantly based on the inhibition of isoprenoid-synthesis [ 37 , 38 ] the biochemical pathway modulating post-translational factors via isoprenylation. The interference of statins with this cellular system of control causes up-/down-regulation of several enzymes participating in inflammation, angiogenesis, redox balance and vascular physiology.…”

Biosensors and biomarkers for determining gestational diabetes mellitus and jaundice in children

“…ELISA is the immunoassay involved with antibody‐based detection system (Figure 3). 60,61 Until now the identification and screening of major diseases are done by ELISA due to its high sensitivity and selectivity without involving the dangerous chemicals such as radioisotope. Single‐step capillary ELISA was conducted by researchers to identify the enzyme reaction using the combination of GOx, antibody and polyethylene glycol containing peroxidase‐labeled antibody in a single capillary 62 .…”